BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study

Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

(2015) Fergus J. Couch et al.   JOURNAL OF CLINICAL ONCOLOGY

MRI breast screening in high-risk women: cancer detection and survival analysis

(2014) Evans D. Gareth et al.   BREAST CANCER RESEARCH AND TREATMENT

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population

(2014) H. Song et al.   HUMAN MOLECULAR GENETICS

Easy-to-Use Decision Aids for Improved Cancer Family History Collection and Use Among Oncology Practices

(2014) Aisha S. Sie et al.   JOURNAL OF CLINICAL ONCOLOGY

Quality of Cancer Family History and Referral for Genetic Counseling and Testing Among Oncology Practices: A Pilot Test of Quality Measures As Part of the American Society of Clinical Oncology Quality Oncology Practice Initiative

(2014) Marie E. Wood et al.   JOURNAL OF CLINICAL ONCOLOGY

PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies

(2013) J.-m. Lee et al.   ANNALS OF ONCOLOGY

Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests

(2013) P. Pujol et al.   BREAST CANCER RESEARCH AND TREATMENT

Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral

(2013) Sarah L. Ingham et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

(2013) Richard M Brohet et al.   JOURNAL OF MEDICAL GENETICS

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months

(2013) Lesley Stafford et al.   PSYCHO-ONCOLOGY

Cognitive and Psychological Impact of BRCA Genetic Counseling in Before and After Definitive Surgery Breast Cancer Patients

(2012) Juliette Christie et al.   ANNALS OF SURGICAL ONCOLOGY

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

(2012) E. A. M. Heijnsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer

(2012) Pawel Gaj et al.   Familial Cancer

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

(2012) Kathryn Alsop et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

(2012) Amanda B Spurdle et al.   JOURNAL OF MEDICAL GENETICS

Personality, physical activity, and symptoms of anxiety and depression: the HUNT study

(2012) Audun Brunes et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Health-related quality of life among women with breast cancer – a population-based study

(2011) Marie Høyer et al.   ACTA ONCOLOGICA

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

(2011) Shiyu Zhang et al.   GYNECOLOGIC ONCOLOGY

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

(2009) Allison W Kurian   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

(2009) D G R Evans et al.   JOURNAL OF MEDICAL GENETICS

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation

(2008) K A Metcalfe et al.   BRITISH JOURNAL OF CANCER

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

(2008) Sharon E. Plon et al.   HUMAN MUTATION